Diagnostics News and Research

RSS

OvaGene's new molecular diagnostics laboratory receives CLIA-certification

OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that the company has received Clinical Laboratory Improvement Act (CLIA) certification for their newly constructed state-of-the-art molecular diagnostics laboratory.

20 Sep 2011

Revolution in drug discovery underway in West Midlands, UK

A revolution in the drug discovery industry is underway, with universities across the West Midlands leading the effort by working in partnership with industry to focus on improving patient care.

19 Sep 2011

St. Mary Medical Center, IMD enter agreement to implement Kidshape 2.0 program in Pennsylvania

St. Mary Medical Center signs licensee agreement with IMD Companies to implement the Kidshape 2.0 program in Pennsylvania. The agreement grants St. Mary the exclusive rights to the KidShape 2.0 program in Bucks County, Pennsylvania. St. Mary will implement the program in its own centers for an initial period of two years, as well as seek new licensees for the program in their territory.

19 Sep 2011

Shannon installs Toshiba's Infinix CF-i single plane vascular X-ray system

Performing cardiac catheterizations through the radial artery is proven to lower the risk of vascular complications, reduce major bleeding and improve patient recovery time when compared to femoral access. Shannon Medical Center, in San Angelo, Texas, installed Toshiba America Medical Systems, Inc.'s Infinix CF-i single plane vascular X-ray system to conduct radial interventions more easily and improve patient safety and outcomes while reducing costs.

19 Sep 2011

Topcon Europe Medical to distribute LensAR product line in Europe

Topcon Europe Medical BV and LensAR Inc announce their intent to enter into a long term strategic cooperation. Topcon Europe Medical BV will be responsible for the distribution and marketing the LensAR product line in Europe.

17 Sep 2011

Hologic to showcase automated systems for cervical cancer screening at IPV, Berlin

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will focus on two new, ready-to-market automated options for cervical cancer screening at the International Papillomavirus Conference & Clinical Workshop (IPV) September 17th through 22nd in Berlin, Germany.

From Hologic, Inc. 17 Sep 2011

Loop-mediated Isothermal Amplification test for human African trypanosomiasis

The Geneva-based not-for-profit foundation FIND and Japanese diagnostics company Eiken announced today that a next-generation molecular test designed specifically for sleeping sickness - a deadly parasitic disease also known as human African trypanosomiasis (HAT) - is ready to enter accelerated field trials in sites across the Democratic Republic of Congo and Uganda.

16 Sep 2011

New insight into why some individuals may be more aggressive than others

Fluctuations of serotonin levels in the brain, which often occur when someone hasn't eaten or is stressed, affects brain regions that enable people to regulate anger, new research from the University of Cambridge has shown.

16 Sep 2011

New GE healthymagination initiative aims to improve cancer innovation and care

GE and leading healthcare and financial partners today launched a new healthymagination initiative aimed at accelerating cancer innovation and improving care for 10 million cancer patients around the world by 2020.

16 Sep 2011

Roche, Uppsala BIO partner for new open innovation program

Swedish life science initiative Uppsala BIO has formed a strategic partnering agreement with Roche, the world leading pharmaceuticals and diagnostics company, for Uppsala BIO's open innovation program, BIO-X.

15 Sep 2011

Fast-track genetic diagnosis for hearing loss

Over 28 million Americans are hearing impaired, and 50 percent of these cases can be traced to genetic causes. The condition can be especially challenging for children born hearing impaired because spoken language, reading, and cognitive development are tied to hearing. That makes early diagnosis essential for identifying appropriate therapy and treatment.

15 Sep 2011

Sanford-Burnham and Scripps Health enter joint translational medicine effort

Scripps Health and Sanford-Burnham Medical Research Institute have formed a collaboration to bridge the gap between laboratory scientists uncovering new approaches for treating cancer and the physicians caring for patients with cancer.

14 Sep 2011

OBT, Seattle Genetics form strategic collaboration to discover novel ADCs for cancer

Seattle Genetics, Inc. and Oxford BioTherapeutics today announced that they have formed a strategic collaboration to jointly discover novel antibody-drug conjugates (ADCs) for cancer.

14 Sep 2011

USU, HJF to host 'The TBI Spectrum' symposium on Sept. 22

New Jersey Congressman and former Philadelphia Eagles offensive lineman Jon Runyan and Army Vice Chief of Staff General Peter Chiarelli will deliver keynote addresses at the fourth USU-HJF Military Medicine Symposium, "The TBI Spectrum," Sept. 22, 2011.

14 Sep 2011

House Research Institute launches hearing loss awareness campaign

House Research Institute has launched a three month nationwide outreach campaign to support the institute's educational initiative It's How You Listen That Counts.

13 Sep 2011

BGI, Merck collaborate to focus on biomarkers and genomic technologies

Merck, known as MSD outside the United States and Canada, and BGI, the world's largest genomics center, announced today that they have established a collaboration to focus on the discovery and development of biomarkers and genomic technologies.

13 Sep 2011

Hawthorn, CoPlex Therapeutics sign licensing deal to develop and commercialize hawAD14 for Alzheimer's

Hawthorn Pharmaceuticals, Inc. announced today an exclusive global licensing deal with CoPlex Therapeutics on hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other neurodegenerative diseases.

13 Sep 2011

Lantus initiation may help limit weight gain in type 2 diabetes patients

Sanofi announced today data that demonstrates that initiating Lantus® (insulin glargine [rDNA origin] injection) in type 2 diabetes patients leads to better glycemic control and comparable and modest weight gain versus a comparator group consisting of other insulins, oral antidiabetics and dietary changes.

12 Sep 2011

FDA grants marketing clearance for WideMed's portable home sleep diagnostic and monitoring solution

WideMed, a leading company engaged in the research, development and sale of innovative products for the growing bio-medical signal diagnostics and treatment market, announced today that the U.S. Food and Drug Administration has granted its home sleep monitoring device, Morpheus Ox, clearance to market in the United States for cardiac patient population.

12 Sep 2011

Sanofi's Lyxumia achieves primary efficacy endpoint in study of patients uncontrolled on metformin

Sanofi announced today that Lyxumia (lixisenatide), a once-daily GLP-1 receptor agonist under development for type 2 diabetes, achieved its primary efficacy endpoint of significant HbA1c reduction vs. placebo in patients uncontrolled on metformin.

12 Sep 2011